• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国各州痴呆症护理成本:医疗支出与无偿护理成本。

The costs of dementia care by US state: Medical spending and the cost of unpaid caregiving.

作者信息

Lastuka Amy, Breshock Michael R, Taylor Kayla V, Dieleman Joseph L

机构信息

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

出版信息

J Alzheimers Dis. 2025 May;105(1):186-196. doi: 10.1177/13872877251326231. Epub 2025 Mar 20.

DOI:10.1177/13872877251326231
PMID:40111940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12231809/
Abstract

BackgroundThere are 5.5 million people living with dementia in the United States (US), with the cost of unpaid care making up a significant portion of the care costs.ObjectiveSummarize variation in the cost of dementia care across the US and examine the association between medical spending and costs of unpaid care at the state level.MethodsWe estimated total cost for dementia by combining recent medical spending estimates from the Disease Expenditure project and unpaid care cost estimates from Lastuka and colleagues. Hours of unpaid care were valued as the hourly wage of a home health aide. We used linear regression to measure the association between the cost of unpaid care and medical spending. The spending that would have occurred if unpaid care had been provided by professional home health care workers was used to measure the cost of unpaid care.ResultsThe annual cost of care attributable to dementia in 2019 was $53,502 (95% uncertainty interval [UI] 46,135-60,594) per case. The contribution of unpaid care to total costs varied by state, ranging from 70.2% (95% UI 64.3-75.4) in the District of Columbia to 89.9% (95% UI 87.8-91.5) in Arizona. We found that higher costs of unpaid care were associated with lower medical spending on nursing facility care.ConclusionsThe large variation in total costs of dementia shows that the economic burden of dementia care is distributed unevenly throughout the US.

摘要

背景

美国有550万人患有痴呆症,无偿护理成本占护理总成本的很大一部分。

目的

总结美国各地痴呆症护理成本的差异,并在州层面研究医疗支出与无偿护理成本之间的关联。

方法

我们通过结合疾病支出项目最近的医疗支出估计数以及Lastuka及其同事的无偿护理成本估计数,估算了痴呆症的总成本。无偿护理时长按家庭健康护理员的小时工资来估值。我们使用线性回归来衡量无偿护理成本与医疗支出之间的关联。如果专业家庭健康护理人员提供无偿护理会产生的支出,被用来衡量无偿护理成本。

结果

2019年,每例痴呆症护理的年度成本为53,502美元(95%不确定区间[UI] 46,135 - 60,594)。无偿护理对总成本的贡献因州而异,从哥伦比亚特区的70.2%(95% UI 64.3 - 75.4)到亚利桑那州的89.9%(95% UI 87.8 - 91.5)。我们发现,无偿护理成本越高,在护理机构护理上的医疗支出就越低。

结论

痴呆症总成本的巨大差异表明,痴呆症护理的经济负担在美国各地分布不均。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca60/12231809/6157354cda13/10.1177_13872877251326231-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca60/12231809/77b1dfbb61ff/10.1177_13872877251326231-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca60/12231809/09d36de5d10e/10.1177_13872877251326231-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca60/12231809/6157354cda13/10.1177_13872877251326231-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca60/12231809/77b1dfbb61ff/10.1177_13872877251326231-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca60/12231809/09d36de5d10e/10.1177_13872877251326231-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca60/12231809/6157354cda13/10.1177_13872877251326231-fig3.jpg

相似文献

1
The costs of dementia care by US state: Medical spending and the cost of unpaid caregiving.美国各州痴呆症护理成本:医疗支出与无偿护理成本。
J Alzheimers Dis. 2025 May;105(1):186-196. doi: 10.1177/13872877251326231. Epub 2025 Mar 20.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Economic Costs Attributed to Diagnosed Diabetes in Each U.S. State and the District of Columbia: 2021.2021年美国各州及哥伦比亚特区确诊糖尿病的经济成本
Diabetes Care. 2024 Aug 9. doi: 10.2337/dc24-0832.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
Consequences, costs and cost-effectiveness of workforce configurations in English acute hospitals.英国急症医院劳动力配置的后果、成本及成本效益
Health Soc Care Deliv Res. 2025 Jul;13(25):1-107. doi: 10.3310/ZBAR9152.
6
Projections of care for older people with dementia in England: 2015 to 2040.英格兰老年痴呆症患者护理展望:2015 年至 2040 年。
Age Ageing. 2020 Feb 27;49(2):264-269. doi: 10.1093/ageing/afz154.
7
Economic Burden of Major Depressive Disorder (MDD), Panic Anxiety, and Generalized Anxiety Disorder (GAD).重度抑郁症(MDD)、惊恐焦虑症和广泛性焦虑症(GAD)的经济负担。
J Ment Health Policy Econ. 2025 Jun 1;28(2):51-58.
8
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
9
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
10
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.

本文引用的文献

1
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球、区域和国家神经障碍疾病负担,1990-2021 年:2021 年全球疾病负担研究的系统分析。
Lancet Neurol. 2024 Apr;23(4):344-381. doi: 10.1016/S1474-4422(24)00038-3. Epub 2024 Mar 14.
2
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
3
U.S. dementia care spending by state: 2010-2019.美国各州的痴呆症护理支出:2010-2019 年。
Alzheimers Dement. 2024 Apr;20(4):2742-2751. doi: 10.1002/alz.13746. Epub 2024 Feb 27.
4
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.1990 - 2022年心血管疾病及其风险的全球负担
J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
5
The worldwide costs of dementia in 2019.2019 年全球痴呆症成本。
Alzheimers Dement. 2023 Jul;19(7):2865-2873. doi: 10.1002/alz.12901. Epub 2023 Jan 8.
6
Gatekeepers: The Association of Caregiving Network Characteristics With Emergency Department Use by Persons Living With Dementia.守门人:与痴呆症患者的急诊使用相关的照顾者网络特征的关联。
J Gerontol B Psychol Sci Soc Sci. 2023 May 26;78(6):1073-1084. doi: 10.1093/geronb/gbac198.
7
The Costs of Dementia in Europe: An Updated Review and Meta-analysis.欧洲的痴呆症成本:一项更新的综述和荟萃分析。
Pharmacoeconomics. 2023 Jan;41(1):59-75. doi: 10.1007/s40273-022-01212-z. Epub 2022 Nov 15.
8
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.评估 1990-2019 年 204 个国家和地区医疗可及性和质量指数的表现,按选定年龄组细分:来自 2019 年全球疾病负担研究的系统分析。
Lancet Glob Health. 2022 Dec;10(12):e1715-e1743. doi: 10.1016/S2214-109X(22)00429-6. Epub 2022 Oct 6.
9
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率:2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
10
Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019.听力损失的患病率和残疾生存年数,1990-2019 年:来自 2019 年全球疾病负担研究的结果。
Lancet. 2021 Mar 13;397(10278):996-1009. doi: 10.1016/S0140-6736(21)00516-X.